vs

Side-by-side financial comparison of Cognizant (CTSH) and DaVita (DVA). Click either name above to swap in a different company.

Cognizant is the larger business by last-quarter revenue ($5.4B vs $3.6B, roughly 1.5× DaVita). Cognizant runs the higher net margin — 12.2% vs 6.5%, a 5.8% gap on every dollar of revenue. On growth, DaVita posted the faster year-over-year revenue change (12.3% vs 5.8%). Over the past eight quarters, DaVita's revenue compounded faster (6.6% CAGR vs 5.6%).

Cognizant Technology Solutions Corporation is an American multinational information technology consulting and outsourcing company originally founded in India. It is headquartered in Teaneck, New Jersey, United States. Cognizant is part of the NASDAQ-100 and trades under CTSH. It was founded in Chennai, India, as an in-house technology unit of Dun & Bradstreet in 1994, and started serving external clients in 1996.

DaVita Inc. is an American company that provides kidney dialysis services through a network of 2,675 outpatient centers in the United States, serving 200,800 patients, and 367 outpatient centers in 11 other countries serving 49,400 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.

CTSH vs DVA — Head-to-Head

Bigger by revenue
CTSH
CTSH
1.5× larger
CTSH
$5.4B
$3.6B
DVA
Growing faster (revenue YoY)
DVA
DVA
+6.5% gap
DVA
12.3%
5.8%
CTSH
Higher net margin
CTSH
CTSH
5.8% more per $
CTSH
12.2%
6.5%
DVA
Faster 2-yr revenue CAGR
DVA
DVA
Annualised
DVA
6.6%
5.6%
CTSH

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CTSH
CTSH
DVA
DVA
Revenue
$5.4B
$3.6B
Net Profit
$662.0M
$234.2M
Gross Margin
Operating Margin
15.6%
15.5%
Net Margin
12.2%
6.5%
Revenue YoY
5.8%
12.3%
Net Profit YoY
-0.2%
43.8%
EPS (diluted)
$1.39
$3.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTSH
CTSH
DVA
DVA
Q1 26
$5.4B
$3.6B
Q4 25
$5.3B
$3.6B
Q3 25
$5.4B
$3.4B
Q2 25
$5.2B
$3.4B
Q1 25
$5.1B
$3.2B
Q4 24
$5.1B
$3.3B
Q3 24
$5.0B
$3.3B
Q2 24
$4.8B
$3.2B
Net Profit
CTSH
CTSH
DVA
DVA
Q1 26
$662.0M
$234.2M
Q4 25
$648.0M
$234.2M
Q3 25
$274.0M
$150.3M
Q2 25
$645.0M
$199.3M
Q1 25
$663.0M
$162.9M
Q4 24
$546.0M
$259.3M
Q3 24
$582.0M
$214.7M
Q2 24
$566.0M
$222.7M
Operating Margin
CTSH
CTSH
DVA
DVA
Q1 26
15.6%
15.5%
Q4 25
16.0%
15.5%
Q3 25
16.0%
14.8%
Q2 25
15.6%
15.9%
Q1 25
16.7%
13.6%
Q4 24
14.8%
17.2%
Q3 24
14.6%
16.4%
Q2 24
14.6%
15.9%
Net Margin
CTSH
CTSH
DVA
DVA
Q1 26
12.2%
6.5%
Q4 25
12.2%
6.5%
Q3 25
5.1%
4.4%
Q2 25
12.3%
5.9%
Q1 25
13.0%
5.1%
Q4 24
10.7%
7.9%
Q3 24
11.5%
6.6%
Q2 24
11.7%
7.0%
EPS (diluted)
CTSH
CTSH
DVA
DVA
Q1 26
$1.39
$3.22
Q4 25
$1.35
$3.22
Q3 25
$0.56
$2.04
Q2 25
$1.31
$2.58
Q1 25
$1.34
$2.00
Q4 24
$1.10
$3.08
Q3 24
$1.17
$2.50
Q2 24
$1.14
$2.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTSH
CTSH
DVA
DVA
Cash + ST InvestmentsLiquidity on hand
$1.5B
$700.7M
Total DebtLower is stronger
$568.0M
$10.2B
Stockholders' EquityBook value
$15.1B
$-651.1M
Total Assets
$20.5B
$17.5B
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTSH
CTSH
DVA
DVA
Q1 26
$1.5B
$700.7M
Q4 25
$1.9B
$700.7M
Q3 25
$2.4B
$736.5M
Q2 25
$1.8B
$739.4M
Q1 25
$2.0B
$511.9M
Q4 24
$2.2B
$846.0M
Q3 24
$2.0B
$1.1B
Q2 24
$2.2B
$437.2M
Total Debt
CTSH
CTSH
DVA
DVA
Q1 26
$568.0M
$10.2B
Q4 25
$10.2B
Q3 25
$10.2B
Q2 25
$10.1B
Q1 25
$9.6B
Q4 24
$9.2B
Q3 24
$9.3B
Q2 24
$8.5B
Stockholders' Equity
CTSH
CTSH
DVA
DVA
Q1 26
$15.1B
$-651.1M
Q4 25
$15.0B
$-651.1M
Q3 25
$14.9B
$-571.9M
Q2 25
$15.3B
$-369.6M
Q1 25
$14.9B
$-267.1M
Q4 24
$14.4B
$121.1M
Q3 24
$14.5B
$386.7M
Q2 24
$13.9B
$632.9M
Total Assets
CTSH
CTSH
DVA
DVA
Q1 26
$20.5B
$17.5B
Q4 25
$20.7B
$17.5B
Q3 25
$20.1B
$17.6B
Q2 25
$20.2B
$17.5B
Q1 25
$20.0B
$17.1B
Q4 24
$20.0B
$17.3B
Q3 24
$20.2B
$17.5B
Q2 24
$18.6B
$17.0B
Debt / Equity
CTSH
CTSH
DVA
DVA
Q1 26
0.04×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
75.76×
Q3 24
23.95×
Q2 24
13.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTSH
CTSH
DVA
DVA
Operating Cash FlowLast quarter
$274.0M
Free Cash FlowOCF − Capex
$198.0M
FCF MarginFCF / Revenue
3.7%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.41×
TTM Free Cash FlowTrailing 4 quarters
$2.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTSH
CTSH
DVA
DVA
Q1 26
$274.0M
Q4 25
$858.0M
$540.7M
Q3 25
$1.2B
$841.5M
Q2 25
$398.0M
$324.2M
Q1 25
$400.0M
$180.0M
Q4 24
$920.0M
$547.6M
Q3 24
$847.0M
$810.4M
Q2 24
$262.0M
$798.8M
Free Cash Flow
CTSH
CTSH
DVA
DVA
Q1 26
$198.0M
Q4 25
$781.0M
$395.3M
Q3 25
$1.2B
$675.4M
Q2 25
$331.0M
$203.1M
Q1 25
$323.0M
$36.8M
Q4 24
$837.0M
$377.0M
Q3 24
$791.0M
$671.4M
Q2 24
$183.0M
$674.1M
FCF Margin
CTSH
CTSH
DVA
DVA
Q1 26
3.7%
Q4 25
14.6%
10.9%
Q3 25
21.4%
19.7%
Q2 25
6.3%
6.0%
Q1 25
6.3%
1.1%
Q4 24
16.5%
11.4%
Q3 24
15.7%
20.6%
Q2 24
3.8%
21.2%
Capex Intensity
CTSH
CTSH
DVA
DVA
Q1 26
Q4 25
1.4%
4.0%
Q3 25
1.2%
4.9%
Q2 25
1.3%
3.6%
Q1 25
1.5%
4.4%
Q4 24
1.6%
5.2%
Q3 24
1.1%
4.3%
Q2 24
1.6%
3.9%
Cash Conversion
CTSH
CTSH
DVA
DVA
Q1 26
0.41×
Q4 25
1.32×
2.31×
Q3 25
4.48×
5.60×
Q2 25
0.62×
1.63×
Q1 25
0.60×
1.10×
Q4 24
1.68×
2.11×
Q3 24
1.46×
3.77×
Q2 24
0.46×
3.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons